1-3 of 3
Jesus San-Miguel
Close
Sort by
Journal Articles

Impact of treatment effect on MRD and PFS: an aggregate data analysis from randomized clinical trials in multiple myeloma

Clinical Trials & Observations
Bruno Paiva, Anastasiia Zherniakova, Jorge M. Nuñez-Córdoba, Paula Rodriguez-Otero, Qian Shi, Nikhil C. Munshi, Brian G. M. Durie, Jesus San-Miguel
Journal: Blood Advances
Blood Adv (2023) 8 (1): 219–223.
https://doi.org/10.1182/bloodadvances.2023010821
Published: 2023
Includes: Supplemental data
Journal Articles

Mass spectrometry vs immunofixation for treatment monitoring in multiple myeloma

Noemí Puig, María-Teresa Contreras, Cristina Agulló, Joaquín Martínez-López, Albert Oriol, María-Jesús Blanchard, Rafael Ríos, Jesús Martín, María-Belén Iñigo, Anna Sureda, Miguel-Teodoro Hernández, Javier de la Rubia, Verónica González-Calle, Isabel Krsnik, Valentín Cabañas, Luis Palomera, José-María Moraleda, Joan Bargay, María-Teresa Cedena, Bruno Paiva, Laura Rosiñol, Joan Bladé, Jesús San Miguel, Juan-José Lahuerta, María-Victoria Mateos
Journal: Blood Advances
Blood Adv (2022) 6 (11): 3234–3239.
https://doi.org/10.1182/bloodadvances.2021006762
Published: 2022
Includes: Supplemental data
Journal Articles

Quantitative expression of Ikaros, IRF4, and PSMD10 proteins predicts survival in VRD-treated patients with multiple myeloma

Clinical Trials & Observations
Irena Misiewicz-Krzeminska, Cristina de Ramón, Luis A. Corchete, Patryk Krzeminski, Elizabeta A. Rojas, Isabel Isidro, Ramón García-Sanz, Joaquín Martínez-López, Albert Oriol, Joan Bladé, Juan-José Lahuerta, Jesús San Miguel, Laura Rosiñol, María-Victoria Mateos, Norma C. Gutiérrez
Journal: Blood Advances
Blood Adv (2020) 4 (23): 6023–6033.
https://doi.org/10.1182/bloodadvances.2020002711
Published: 2020
Includes: Supplemental data